MedTrace Logo

Effect of Vitamin D Intake in Pregnancy to Prevent Recurrence of Gestational Diabetes

NCT03701087 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 430

Last updated 2018-10-09

No results posted yet for this study

Summary

primary outcome is vitamin D intake in first trimester for pregnant women with history of gestational diabetes in previous pregnancies and incidence of gestational diabetes recurrence secondary outcome is effect of vitamin D intake on mode of delivery, apgar score and neonatal birth weight

Conditions

  • Vitamin D Intake in First Trimester and Incidence of Gestational Diabetes Recurrence

Interventions

DRUG

Vitamin D

2800 IU daily till 26 weeks of pregnancy

Sponsors & Collaborators

  • Kasr El Aini Hospital

    lead OTHER

Principal Investigators

  • ashraf mohsen, lecturer · Investigator

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-02
Primary Completion
2020-02-02
Completion
2020-04-02

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03701087 on ClinicalTrials.gov